The largest gift ever to the health system will be used to establish the unit in the remaining unoccupied three floors of Cambridge Tower A, where the Blood and Marrow Transplant (BMT) Program and Division of Hematologic Malignancies & Cellular Therapy (HMCT) will be located. BMT treats patients with blood cancers and disorders such as leukemia, lymphoma, multiple myeloma, and sickle cell disease, while HMCT is a hub of the system's cancer care, including the development of a robust Translational Science Research and CAR-T/Cellular Therapy Program. The new space also will feature family and patient education centers in order to create a holistic care experience — something that is particularly important in immunotherapy treatments requiring significant inpatient time.
"The Sunderland Foundation grant will help meet a critical need for our patients who currently receive care from multiple locations," said HMCT division director Joseph McGuirk. "This new dedicated space will allow us to treat more than twenty-five hundred patients over the next ten years in an environment that ultimately will bring our full interdisciplinary team onto the same campus improving the patient experience and outcomes."
"We primarily make contributions to nonprofit construction projects where people in distress can find hope and healing," said Charlie Sunderland, secretary and treasurer of the board of the Sunderland Foundation. "Construction is our vehicle, but we're really investing in people."